Telix Pharmaceuticals’ expansion phase shows no sign of running out yet, with the Australian radiopharma company paying $45 million in…

Blueprint Medicines is cutting funding to its clinical-stage CDK2 inhibitor even as the Ayvakit-maker pushes forward with similar preclinical breast…

Investors clearly appreciate the song that Tune Therapeutics is singing, handing over $175 million in series B funds as the…

Ecologists at the University of Hong Kong (HKU) have unveiled groundbreaking discoveries that promise to reshape conservation strategies for two…

The challenge of overcoming resistance mechanisms in advanced non-small cell lung cancer (NSCLC) has been a persistent focus in thoracic…

The fight against lung cancer, the leading cause of cancer-related deaths worldwide, has taken a transformative leap forward with the…

A new study published in Nature Human Behaviour unveils the intricate biological links between social isolation, loneliness, and a plethora…

The successful transplantation of a genetically modified porcine heart into a living human marks a significant milestone in the field…

The advent of blood-based cancer screening has brought hope and excitement to the medical community, particularly in the field of…

Scientists have uncovered a transformative mechanism that explains the aggressive behavior of lung metastases in breast cancer. The research, published…